ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

UNCY Unicycive Therapeutics Inc

1.10
-0.02 (-1.79%)
Pre Mercado
Última actualización: 07:22:20
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Unicycive Therapeutics Inc UNCY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.02 -1.79% 1.10 07:22:20
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.12
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/4/202406:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
28/3/202415:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
25/3/202406:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
14/3/202406:03GLOBEUnicycive Announces $50 Million Private Placement
13/3/202406:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
07/3/202415:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
04/3/202406:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
21/2/202415:06EDGAR2Form 8-K - Current report
14/2/202406:03GLOBEUnicycive Therapeutics to Present Two Posters on..
29/1/202406:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
23/1/202406:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
22/1/202415:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202306:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
08/12/202315:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/11/202306:03GLOBEUnicycive Therapeutics to Participate in Two Investor..
14/11/202315:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202315:15GLOBEUnicycive Announces Third Quarter 2023 Financial Results and..
23/10/202310:12EDGAR2Form 8-K - Current report
23/10/202306:03GLOBEUnicycive Therapeutics Reaches Alignment with the FDA on..
25/9/202315:05EDGAR2Form 8-K - Current report
07/9/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202315:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202308:16EDGAR2Form 8-K - Current report
06/9/202306:03GLOBEUnicycive Therapeutics Strengthens Board of Directors with..
31/8/202315:16EDGAR2Form 8-K - Current report
30/8/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202315:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202306:03GLOBEUnicycive Therapeutics Featured on Nasdaq Amplify Issuer..
14/8/202316:36GLOBEUnicycive Announces Second Quarter 2023 Financial Results..
14/8/202316:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202315:15EDGAR2Form 8-K - Current report
26/7/202305:05EDGAR2Form 8-K - Current report
20/7/202306:03GLOBEUnicycive Therapeutics to Participate in the H.C. Wainwright..
18/7/202306:03GLOBEUnicycive Therapeutics Announces Publication of Positive..
14/7/202315:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/7/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202318:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202316:04GLOBEUnicycive Therapeutics Provides Regulatory Update on..
16/6/202306:38GLOBEUnicycive to Participate in the Healthcare Virtual..
16/5/202307:29GLOBEUnicycive Announces First Quarter 2023 Financial Results and..

Su Consulta Reciente

Delayed Upgrade Clock